|
|
|
TOTAL CHOLESTEROL PROCEDURE
Intended for the Quantitative Determination of Serum Total Cholesterol
SUMMARY AND EXPLANATION
Total serum cholesterol has proved useful in the diagnosis of hyperlipoptoteinemia,
atherosclerosis, hepatic and thyroid diseases (1). Total and HDL cholesterols, in conjunction
with a triglyceride determination, provide valuable information for the prediction of the
coronary heart disease (2), and for lipoprotein phenotyping according to the Fredrickson
classification (3).
The SUMMIT TOTAL CHOLESTEROL PROCEDURE is based on a modified enzymatic
method first described by Allain et al (4). P-Hydroxybenzene sulfonate replaces phenol in the
formulation providing a safer, less corrosive reagent.
PRINCIPLE
The cholesterol assay involves sequential enzymatic reactions. Cholesterol esterase hydrolyzes
cholesterol esters to cholesterol and free fatty acids. Cholesterol oxidase then oxidizes
cholesterol to form cholest-4-en-3-one and hydrogen peroxide. Peroxidase catalyzes the
hydrogen peroxide oxidation of 4-aminophenazone with subsequent coupling to p-hydroxybenzensulfonate. The end product is a quinoneimine dye which absorbs at 520 nm. The
color intensity at 520 nm is directly proportional to serum cholesterol concentration.
REAGENTS: FOR IN-VITRO DIAGNOSTIC USE
Reagent Set Cat. No. 2500 provides:
CHOLESTEROL REAGENT - (Cat. No. 2501)
REACTIVE INGREDIENTS:
After reconstitution, cholesterol esterase - 150 U/L; cholesterol oxidase - 200 U/L; peroxidase -
1500 U/L; 4-aminophenazone - 0.6 mM; p-hydroxybenzenesulfonate - 20 mM. Buffer, stabilizer
and surfactant added.
RECONSTITUTION:
Add entire contents of the vial to amount of D-H2O indicated on label. Mix gently to dissolve.
PRECAUTIONS:
Do not ingest. Toxicity has not been established. Causes irritation, avoid contact with skin, eyes
and clothing. In case of contact, wash with large amount of water.
STORAGE AND STABILITY:
Store at 2 - 8° C. Stable until expiration date if sealed tightly. After reconstitution, the reagent is stable for 60 days at 2 - 8° C. PROTECT FROM LIGHT.
DETERIORATION:
The reagent should be a dry powder. Moisture entering the vial can be detected by observing for
caking of the reagent powder. After reconstitution, failure to achieve assayed values of freshly
prepared control sera would indicate deterioration and the reagent should not be used.
CHOLESTEROL CALIBRATOR - (Cat. No. 2502)
REACTIVE INGREDIENTS:
200 mg/dL cholesterol in alcohol.
PRECAUTIONS:
Do not ingest. Causes irritation, avoid contact with skin, eyes and clothing. In case of contact,
wash with large amount of water.
STORAGE AND STABILITY:
Store at 2 - 8° C. Stable until expiration date if sealed tightly.
DETERIORATION:
The calibrator should be a clear, colorless solution. Turbidity would indicate deterioration.
INSTRUMENTS
Use a spectrophotometer or colorimeter calibrated at 520 nm.
PRECAUTIONS:
1. Unhemolyzed serum collected after a 12 hour fast is recommended.
2. Plasma may be used if blood is collected in EDTA or heparin.
3. A non-fasting specimen may be used if the sample is not turbid.
4. Turbid / Lipemic samples require a Serum Blank.
SAMPLE STORAGE:
Serum cholesterol appears stable for 5 days at 2 - 8° C.
ADDITIVES:
No special additives or preservatives are needed.
INTERFERING SUBSTANCES:
Bilirubin above the normal range will depress the cholesterol value approximately 2 mg/dL for
each 1 mg/dL billirubin. Gentisic acid significantly affects the enzymatic cholesterol assay.
Oxalate, flouride and citrate interfere with the procedure.
Young et al (5) have reviewed drug effects on serum cholesterol levels.
PROCEDURE
MATERIALS PROVIDED:
CHOLESTEROL REAGENT (Cat. No. 2501) and CHOLESTEROL CALIBRATOR (Cat. No.
2502).
MATERIALS REQUIRED BUT NOT PROVIDED:
1. 0.01 mL micropipettor
2. 1.0 mL pipettor or dispensor
3. Incubator capable of maintaing 37° C
4. Timer, test tubes and rack
REACTION CONDITIONS:
Wavelength 520 nm
Filter Selection 500 - 550 nm
Reaction Type Endpoint
Reaction Time 10 minutes at 37° C
and Temperature 15 minutes at 30° C
20 minutes at 25° C
Sample Volume 0.01 mL
Reagent Volume 1.0 mL
Total Volume 1.01 mL
Low Normal 135 mg/dL
High Normal 200 mg/dL
Calibrator 200 mg/dL
AUTOMATED PROCEDURE:
Refer to specific instrument application for instructions.
MANUAL PROCEDURE:
PROCEDURAL NOTE: For instruments requiring a total volume of 1.0 mL, increase
CHOLESTEROL REAGENT volume to 2.0 mL and Sample volume to 0.02 mL. Proceed as
outlined.
1. Dispense 1.0 mL CHOLESTOL REAGENT into tubes labeled: Reagent Blank, Calibrator, Control, Sample 1, etc.
2. Prewarm for five minutes at 37° C.
3. Place 0.01 mL Specimen into appropriately labeled tube and mix well. Use D-H2O as sample for Reagent Blank.
4. Incubate all tubes at 37° C for 10 minutes.
5. Zero instrument at 520 nm using Reagent Blank.
6. Read and record absorbances for Calibrator, Control and Unknowns.
NOTE: For a direct read-out instrument, set read-out to concentration of Calibrator and read the
Unknown concentration directly.
SERUM BLANK:
Highly lipemic Specimens require a Serum Blank.
1. Add 0.01 mL serum to 1.00 mL 0.9% sodium chloride solution.
2. Zero instrument at 520 nm with 0.9% sodium chloride solution.
3. Read and record absorbance of Serum Blank.
4. Subtract blank absorbance from sample test absorbance measured in Step 6 of
PERFORMANCE OF TEST. Use this value in calculating the total cholesterol concentration.
STABILITY OF FINAL REACTION PRODUCT:
The test sample should be read within 30 minutes after color development.
CALIBRATION:
It is not necessary to perform a calibration curve with this procedure since the reaction is linear
in the range of 0-600 mg/dL. However, a Calibrator and Reagent Blank must be determined with
each set of Unknowns assayed. Use CHOLESTEROL CALIBRATOR (Cat. No. 2502) which is
provided with the reagent set or other suitable calibration material for this purpose. Specimens
exceeding 600 mg/dL should be diluted with 0.9% sodium chloride solution and reassayed.
Multiply the test result by the dilution factor to obtain the final answer.
QUALITY CONTROL:
The reliability of test results should be monitored routinely using suitable quality control
materials (normal and abnormal) analyzed in the same manner used for the Unknowns. Failure
to achieve assayed values of freshly prepared control sera must be thoroughly investigated
before patient results are reported.
CALCULATION OF RESULTS
The following equation is used to determine Unknown concentrations:
Unknown (mg/dL) =
Unk. Abs.
-------------- X Cal. Conc. (mg/dL)
Cal. Abs.
EXAMPLE:
A 200 mg/dL Calibrator has Abs. = 0.328 while the Unknown Abs. = 0.265. The cholesterol
concentration of the Unknkown is:
0.265
--------- X 200 mg/dL = 162 mg/dL
0.328
NOTE: To convert from mg/dL to SI units (mM/L), multiply the result in mg/dL by 10 dL/L and
divide by 386.6 mg/mM.
LIMITATIONS
Several cholesterol analogs also react with cholesterol oxidase, but these substances appear in
very small amounts in serum (4).
EXPECTED VALUES (6)
Recommended 200 mg/dL
Moderate 200 - 239 mg/dL
High Risk 240 mg/dL
This range is taken from literature reference (6). Since cholesterol values vary with age, diet,
exercise and geographic location (1), it is recommended that each laboratory establish its own
range of expected values. Reference ranges based on an apparently healthy population are
generally higher than the recommended (desirable) levels for adults. The EXPECTED VALUES
as presented is the "recommended" (desirable) level for adults and the adult levels in term of
risk for coronary heart disease.
PERFORMANCE CHARACTERISTICS
LINEARITY:
This procedure is linear to 600 mg/dL.
PRECISION:
Normal and abnormal control sera were assayed 20 times each for within run precision and for
10 working days to estalbish run to run precision.
WITHIN RUN
MEAN / ST. DEV. / %CV
Normal 135 / 1.3 / 1.0
Abnormal 335 / 2.9 / 1.0
RUN TO RUN
Normal 139 / 2.1 / 1.5
Abnormal 342 / 4.9 / 1.4
SPECIFICITY:
A comparison of this TOTAL CHOLESTEROL PROCEDURE with another widely used
commercial method showed a 99% correlation with samples in the normal and abnormal range.
SENSITIVITY:
This TOTAL CHOLESTEROL PROCEDURE has a sensitivity of 0.6 mg/dL per 0.001
absorbance unit.
REFERENCES
1. Tiez, N.W., Fundamentals of Clinical Chemistry, 2nd ed., W.B. Saunders Co., Philadelphia, 1982, p. 506.
2. Gordon, T., Castelli, W.P., Hjortland, M.C., Kannel, W.B., and Dawber, T.R., Amer. J. Med., 62, 707 (1977).
3. World Health Organization Memorandum: Classification of Hyperlipidemias and Hyperlipoproteinemias. Circulation 45, 501 (1972).
4. Allain, C.C., Poon, L.S., Chan, C.S.G., Richmond, W., and FU, P.C., Clin. Chem. 20, 470 (1974).
5. Young, D.S., Pestaner, L.C. and Gibberman, V., Clin. Chem., Vol. 21, p. 278D (1975).
6. The Expert Panel: Report of the National Cholesterol Education Program Expert Panel
on detection, evaluation and treatment of high blood cholesterol in adults. Arch. Int. Med., 148:
36 - 39, 1988.